Study of AND017 for anemia in cancer patients not on chemo
Treatments studied
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests an experimental drug called AND017 to treat anemia (low red blood cells) in people with cancer who are not currently receiving chemotherapy. The goal is to see if it can raise hemoglobin levels and improve energy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of cancer that does not start in the bone marrow (non-myeloid cancer).
- You are able to take care of yourself (ECOG score 0-2) and are expected to live at least 6 months.
- Your average hemoglobin level from two tests (taken more than a week apart) is less than 10 g/dL, and the levels did not change much between tests.
- Your liver and kidneys are working well enough (based on standard blood tests).
- You have not had chemotherapy, radiation, or other treatments that suppress bone marrow in the last month and do not plan to start them during the trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, AND017, to see if it can help raise hemoglobin levels in people with cancer who have anemia from chemotherapy. It's for patients with non-blood cancers who are still receiving certain types of chemo or targeted therapy.
This trial tests an experimental drug called AND017 for people with a certain type of myelodysplastic syndrome (MDS) that is low-risk and not linked to a chromosome 5 deletion. The goal is to see if AND017 can help improve low red blood cell counts (anemia) and reduce or avoid the need for blood transfusions.
This trial tests an oral medication (AND017) for anemia caused by chronic kidney disease. It aims to improve red blood cell levels without needing dialysis or current anemia treatments.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This study tests a new medication (SAL-0951) for treating low red blood cell counts (anemia) caused by chemotherapy in people with certain types of cancer that are not curable. It may help improve energy and reduce the need for blood transfusions.
This trial tests an oral medication called AND017 for people with beta-thalassemia. It aims to see if the drug can safely help reduce the need for blood transfusions or improve hemoglobin levels.
Hear when a new Cancer-Related Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.